Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133438) titled 'Exploring Clinical and Molecular Features Associated with Early Efficacy Heterogeneity of Ivarmacitinib in the Treatment of Atopic Dermatitis: A Prospective Cohort Study' on Sept. 28.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Army Medical University
Condition:
Atopic dermatitis
Atopic eczema
Intervention:
Delayed?response group:None
Moderate?response group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-30
Target Sample Size: Delayed?response group:10;Moderate?response group:38;Rapid-response group:4...